In a study published in Nature, a University of Pittsburgh team found that eating creates a temporary metabolic state that influences the function of T cells – immune cells that help the body detect and fight infection and disease, including cancer. In experiments in mice and humans, T cells collected after a meal showed a metabolic and functional advantage over those collected after fasting. The findings suggest that eating can have a lasting effect on how immune cells respond when they are activated – a factor that could be relevant for T cell–based immunotherapies, such as CAR‑T cell therapy, as well as for responses to infection.
That durability matters because most T cells are not activated immediately after eating. However, if a T cell encounters a pathogen while this post‑meal metabolic advantage is still present, it responds more strongly, linking a short‑term nutritional state to a later immune response.
Follow‑up experiments in mice confirmed that eating creates a temporary opportunity for T cells to obtain nutrients. Some of those cells retained a functional advantage and responded better if they were activated later, up to seven days afterward. The effect was driven by fats circulating in the bloodstream after a meal. These fats, carried in particles called chylomicrons, were sufficient to enhance T cell function, showing that immune cells can directly access and use dietary lipids.
“Piecing together the biology behind this effect required a broad collaborative effort at Pitt,” said Delgoffe, who also directs the Tumor Microenvironment Center at UPMC Hillman Cancer Center. “It brought together expertise in nutrition, metabolism and immunology to understand what was really happening inside these cells.”
How eating could be shaping T Cells in cancer therapy #
The findings have particular relevance for cancer immunotherapy, including CAR‑T cell therapy. In this approach, T cells are collected from a patient’s blood, modified in the laboratory to recognize cancer cells and then reinfused into the patient to attack the tumor.
While the findings point to new biological insights, the study does not suggest that eating treats cancer or that patients should change their diets. Instead, it highlights timing as a critical and previously overlooked variable. By showing how immune cell performance can vary depending on metabolic state, the work points to new ways researchers might think about when immune cells are collected, activated or analyzed.
Citation #
- The study Postprandial lipid metabolism durably enhances T cell immunity was published in Nature magazine. Authors: Alok Kumar, Dayana B. Rivadeneira, Isha Mehta, Bingxian Xie, Rachel Cumberland, Supriya K. Joshi, Jitendra S. Kanshana, William G. Gunn, Victoria Dean, Angelina Parise, Kristin Morder, Erica S. Myers, Steven J. Mullett, Richard T. Cattley, Stacy L. Gelhaus, Abigail E. Overacre-Delgoffe, Jishnu Das, William F. Hawse, Alison B. Kohan & Greg M. Delgoffe
Kumar, A., Rivadeneira, D.B., Mehta, I. et al. Postprandial lipid metabolism durably enhances T cell immunity. Nature (2026). https://doi.org/10.1038/s41586-026-10432-8
Received 07 March 2025
Accepted 19 March 2026
Published 29 April 2026
Version of record 29 April 2026
DOI https://doi.org/10.1038/s41586-026-10432-8
Funding #
This study was supported by National Institutes of Health (DP2AI136598, R01AI171483, R01AI166598, R01CA277473, DP2AI177967, R01AI175111, NIHS10OD032141 and NIHS10OD023402), Cancer Research Institute Lloyd J. Old STAR Award (CRI3447), Mark Foundation for Cancer Research’s Emerging Leader Award (19-040-ELA), Sy Holzer Endowed Immunotherapy Fund, The Pittsburgh Foundation (MR2023-134140), UPMC Hillman Cancer Center Skin Cancer and Head and Neck Cancer SPOREs (P50CA121973 and P50CA097190; NIH), and the Hillman Fellows for Innovative Cancer Research Program.
Contact [Notaspampeanas](mailto: notaspampeanas@gmail.com)